SELLAS Life Sciences Group, Inc. — Director's Dealing 2015

Feb 13, 2015

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2014-12-31

Reporting Person: Hillsberg Sanford (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-03	Common Stock	G	10000	—	Disposed	85447	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	17974	Direct